当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析

和邦生物

(603077)

  

流通市值:181.92亿  总市值:181.92亿
流通股本:88.31亿   总股本:88.31亿

和邦生物(603077)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.96亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1938078.89万元,未分配利润983894.23万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2597531.27万元,负债659452.38万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入6,813,692,192.924,848,440,513.181,999,261,196.48,824,107,811.82
营业总成本6,550,036,297.84,604,210,077.71,944,326,999.847,325,629,073.21
营业利润260,299,739.07245,767,298.443,612,198.851,541,792,116.14
利润总额259,501,458.7245,320,877.1243,608,602.021,535,965,520.99
净利润195,536,979.04188,048,359.5527,143,210.751,278,699,260.63
其他综合收益-33,076,482.29-16,366,1711,488,590.7431,687,239.44
综合收益总额162,460,496.75171,682,188.5528,631,801.491,310,386,500.07
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计10,828,282,355.3211,135,509,365.210,808,114,490.39,854,626,292.04
非流动资产合计15,147,030,324.615,087,400,337.0414,830,900,085.2314,687,807,830.81
资产总计25,975,312,679.9226,222,909,702.2425,639,014,575.5324,542,434,122.85
流动负债合计5,762,231,159.45,693,927,932.455,090,318,548.143,669,941,850.66
非流动负债合计832,292,622.49911,417,584.52874,308,696.95654,110,050.9
负债合计6,594,523,781.896,605,345,516.975,964,627,245.094,324,051,901.56
归属于母公司股东权益合计18,764,699,737.5118,978,485,274.5619,033,820,331.8219,575,342,485.28
股东权益合计19,380,788,898.0319,617,564,185.2719,674,387,330.4420,218,382,221.29
负债和股东权益合计25,975,312,679.9226,222,909,702.2425,639,014,575.5324,542,434,122.85
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计5,330,288,586.73,466,445,308.191,401,050,252.766,438,680,798.86
经营活动现金流出小计5,467,511,402.223,569,929,423.411,834,423,591.336,358,349,014.53
经营活动产生的现金流量净额-137,222,815.52-103,484,115.22-433,373,338.5780,331,784.33
投资活动现金流入小计24,155,473.9110,441,856.144,911,030.97280,497,909.28
投资活动现金流出小计788,665,017.11511,395,927.88244,612,808.671,062,724,494.23
投资活动产生的现金流量净额-764,509,543.2-500,954,071.74-239,701,777.7-782,226,584.95
筹资活动现金流入小计2,869,202,966.792,494,399,219.581,531,191,082.471,858,723,703.99
筹资活动现金流出小计2,501,497,326.91,944,509,347.41,111,827,029.552,802,320,418.97
筹资活动产生的现金流量净额367,705,639.89549,889,872.18419,364,052.92-943,596,714.98
汇率变动对现金及现金等价物的影响-4,277,0814,612,832.96-73,739.745,465,273.51
现金及现金等价物净增加额-538,303,799.83-49,935,481.82-253,784,803.09-1,640,026,242.09
期末现金及现金等价物余额2,366,528,042.252,854,896,360.262,651,047,038.992,904,831,842.08
TOP↑